The chronic condition most associated with accumulating multiple head injuries is chronic traumatic encephalopathy, commonly known as CTE. It is a progressive brain disease caused by repeated impacts to the head over months or years, leading to a buildup of abnormal proteins that slowly destroy brain tissue. CTE has been found in the brains of professional athletes, military veterans, and others with histories of repetitive head trauma.
What Happens Inside the Brain
CTE develops when a specific protein, called tau, begins accumulating in an abnormal pattern deep within the folds of the brain’s outer surface. In a healthy brain, tau helps stabilize the internal structure of nerve cells. After repeated head impacts, tau proteins become misfolded and clump together around small blood vessels at the base of these folds, particularly in the frontal cortex. Over time, these clumps spread outward and deeper into the brain, killing neurons and triggering inflammation along the way.
This pattern of damage is distinct from other brain diseases. While Alzheimer’s disease also involves tau buildup, the specific location and distribution in CTE is unique enough for neuropathologists to distinguish the two under a microscope. The tau deposits in CTE cluster around blood vessels at the depths of cortical grooves, a pattern not seen in Alzheimer’s or normal aging.
Subconcussive Hits Matter More Than Concussions
One of the most important findings in CTE research challenges a common assumption: the total number of concussions a person has suffered is not the primary driver of the disease. Instead, cumulative exposure to repetitive head impacts, including hits that never cause concussion symptoms, is what correlates most strongly with the severity of tau buildup. The number of years spent in contact sports is significantly associated with worse brain pathology, regardless of how many diagnosed concussions occurred during that time.
This means that the thousands of smaller, subconcussive hits absorbed during practices and games may be more dangerous in aggregate than the occasional big hit that causes obvious symptoms. About 16% of confirmed CTE cases had no documented history of concussion at all, suggesting that subconcussive impacts alone can be sufficient to trigger the disease.
Who Is Most at Risk
CTE has been found most frequently in people with long careers in contact sports. In one brain bank study of 202 former American football players, 87% had CTE. Among those who played in the NFL, the rate was 99%. These numbers come from donated brains, so they likely overrepresent people who experienced symptoms during life, but they still demonstrate how strongly repetitive head trauma correlates with the disease.
Beyond athletes, CTE affects military service members, victims of domestic abuse, people with epilepsy who experience repeated falls, and anyone else exposed to ongoing head impacts. Military personnel with blast exposure histories showed a higher relative risk compared to those without blast exposure, though the numbers in that particular study were small. The common thread across all these groups is years of repeated trauma to the head, not a single catastrophic injury.
How CTE Progresses Over Four Stages
Researchers have identified four pathological stages of CTE based on how far tau deposits have spread through the brain. These stages were defined by examining brains after death, but each corresponds to increasingly severe symptoms during life.
In Stage I, only one or two small clusters of abnormal tau appear around blood vessels in the frontal cortex. Dementia is uncommon at this point, occurring in about 23% of cases. People may experience headaches, difficulty concentrating, or subtle mood changes that are easy to dismiss.
By Stage II, three or more clusters have appeared across multiple brain regions, and tau begins spreading into deeper structures involved in memory and emotional regulation. Dementia frequency rises to about 47%. Depression, impulsivity, and short-term memory problems become more noticeable.
Stage III brings large, merging patches of tau throughout the cortex and into the hippocampus, amygdala, and brainstem. Visible brain shrinkage and enlarged fluid-filled spaces become apparent. About 65% of people at this stage have dementia, and behavioral symptoms like aggression, poor judgment, and significant memory loss are common.
Stage IV represents the most severe form. Tau has spread throughout virtually the entire brain, including the spinal cord. Nerve cells in regions that produce key brain chemicals have died, and widespread tissue loss is obvious. Dementia is present in over 92% of cases. At this stage, individuals typically need full-time care.
How CTE Differs From Post-Concussion Syndrome
People sometimes confuse CTE with post-concussion syndrome, but the two conditions are fundamentally different. Post-concussion syndrome is a short-term consequence of a single traumatic brain injury. Symptoms like headaches, dizziness, and difficulty concentrating typically resolve within a few weeks or months. In some cases, persistent post-concussion symptoms may last longer and could signal a risk for further complications, but the condition itself does not involve progressive neurodegeneration.
CTE, by contrast, is a long-term consequence of repeated brain injuries. It involves actual structural changes to the brain that worsen over time, even after the person has stopped being exposed to head impacts. Symptoms tend to appear years or even decades after the period of exposure, and they do not improve. The delay between the end of a playing career or military service and the onset of noticeable cognitive or behavioral problems can span many years, which makes the connection between cause and effect difficult to recognize without knowing the person’s history.
Why Diagnosis Remains Difficult
CTE can currently only be confirmed after death, through microscopic examination of brain tissue. No blood test, brain scan, or clinical exam can definitively diagnose it in a living person. Different diagnostic criteria exist for clinical and research purposes, but their accuracy remains unclear.
That may be changing. The NIH recently awarded $15 million to a Boston University-led project called DIAGNOSE CTE Research Project-II, which is working to identify biological markers of CTE in living patients. The study uses blood draws, advanced brain imaging, and a specialized scan that highlights tau protein deposits, combined with extensive cognitive and neuropsychiatric testing. The goal is to develop a reliable way to detect CTE before death, which would be a major step toward earlier intervention.
Treatment Options Today
There is no treatment that stops or reverses CTE. The brain damage is progressive, and symptoms worsen over time. Current management focuses entirely on addressing individual symptoms as they arise. Cognitive behavioral therapy can help with depression and anxiety, and certain medications may ease mood-related symptoms, but nothing targets the underlying disease process.
Because of this, prevention is the only effective strategy. Reducing the number and severity of head impacts, particularly in youth and amateur sports, limiting unnecessary contact during practices, and improving protective equipment all aim to lower cumulative exposure. For anyone with a long history of repetitive head impacts, awareness of the early signs (mood changes, memory difficulties, impulsivity) can help prompt supportive care sooner, even without a definitive diagnosis.